Autoimmune nodopathy: clinical features
Evidence-based neurology checklist on autoimmune nodopathy: clinical features: Epidemiology Affected subjects are usually adults Males are more frequently affected Diabetes may be a risk factor Clinical features Associated features: especially with panNF Associated features: especially with NF155…
Epidemiology
- Affected subjects are usually adults
- Males are more frequently affected
- Diabetes may be a risk factor
Clinical features
Associated features: especially with panNF
Associated features: especially with NF155
Phenotypes
Differential diagnosis
Synonym
References
- Fehmi J, Vale T, Keddie S, Rinaldi S. Nodal and paranodal antibody-associated neuropathies. Pract Neurol 2021 (Online ahead of print).
- Appeltshauser L, Messinger J, Starz K, et al. Diabetes mellitus is a possible risk factor for nodo-paranodopathy with antiparanodal autoantibodies. Neurol Neuroimmunol Neuroinflamm 2022; 9:e1163.
- Cortese A, Lombardi R, Briani C, et al. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. Neurol Neuroimmunol Neuroinflamm 2019; 7:e639.
- Martín-Aguilar L, Lleixà C, Pascual-Goñi E, et al. Clinical and laboratory features in anti-NF155 autoimmune nodopathy. Neurol Neuroimmunol Neuroinflamm 2021; 9:e1098.
- Fehmi J, Davies AJ, Walters J, et al. IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality. JNNP 2021; 92:1089-1095.
- And 7 more. Subscribe to see the full list
